APO Research

APO RESEARCH · REPORT

AI Therapy Chatbots

Selected research

Market Outlook & Growth Opportunities

Global AI Therapy Chatbots Market Outlook and Growth Opportunities 2026

Market perspective

The global AI Therapy Chatbots market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for AI Therapy Chatbots is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI Therapy Chatbots is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI Therapy Chatbots is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the AI Therapy Chatbots market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the AI Therapy Chatbots market include MIT(Eliza), Pear Therapeutics, Woebot Health, Expresso, Wysa, X2AI, Huma, Youper and Replika, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global AI Therapy Chatbots market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI Therapy Chatbots and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI Therapy Chatbots revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI Therapy Chatbots market.

AI Therapy Chatbots Segment by Company

MIT(Eliza)

Pear Therapeutics

Woebot Health

Expresso

Wysa

X2AI

Huma

Youper

Replika

Mindstrong Health

Marigold Health

Miyourobot

Xinchenai

Ai-beings

Leading-ai

Pku

Lx-tech

Csjbot

AI Therapy Chatbots Segment by Type

Rogerian Psychotherapy

Cognitive Behavior Therapy

AI Therapy Chatbots Segment by Application

To C

To B

To G

Others

AI Therapy Chatbots Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global AI Therapy Chatbots status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the AI Therapy Chatbots key companies, revenue, market share, and recent developments.

3. To split the AI Therapy Chatbots breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions AI Therapy Chatbots market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify AI Therapy Chatbots significant trends, drivers, influence factors in global and regions.

6. To analyze AI Therapy Chatbots competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Therapy Chatbots market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Therapy Chatbots and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Therapy Chatbots.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Therapy Chatbots industry.

Chapter 3: Detailed analysis of AI Therapy Chatbots company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of AI Therapy Chatbots in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of AI Therapy Chatbots in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. AI Therapy Chatbots Industry Trends Table 2. AI Therapy Chatbots Industry Drivers Table 3. AI Therapy Chatbots Industry Opportunities and Challenges Table 4. AI Therapy Chatbots Industry Restraints Table 5. Global AI Therapy Chatbots Revenue by Company (US$ Million) & (2021-2026) Table 6. Global AI Therapy Chatbots Revenue Share by Company (2021-2026) Table 7. Global AI Therapy Chatbots Company Ranking, (2024-2026) & (US$ Million) Table 8. Global AI Therapy Chatbots Key Company Manufacturing Base & Headquarters Table 9. Global AI Therapy Chatbots Company, Product Type & Application Table 10. Global AI Therapy Chatbots Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global AI Therapy Chatbots by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Rogerian Psychotherapy Table 15. Significant Companies of Cognitive Behavior Therapy Table 16. Global AI Therapy Chatbots Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global AI Therapy Chatbots Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global AI Therapy Chatbots Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global AI Therapy Chatbots Sales Value Share by Type (2021-2026) Table 20. Global AI Therapy Chatbots Sales Value Share by Type (2027-2032) Table 21. Significant Companies of To C Table 22. Significant Companies of To B Table 23. Significant Companies of To G Table 24. Significant Companies of Others Table 25. Global AI Therapy Chatbots Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global AI Therapy Chatbots Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global AI Therapy Chatbots Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global AI Therapy Chatbots Sales Value Share by Application (2021-2026) Table 29. Global AI Therapy Chatbots Sales Value Share by Application (2027-2032) Table 30. Global AI Therapy Chatbots Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global AI Therapy Chatbots Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global AI Therapy Chatbots Sales Value Share by Region (2021-2026) Table 33. Global AI Therapy Chatbots Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global AI Therapy Chatbots Sales Value Share by Region (2027-2032) Table 35. Global AI Therapy Chatbots Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global AI Therapy Chatbots Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global AI Therapy Chatbots Sales Value Market Share by Country (2021-2026) Table 38. Global AI Therapy Chatbots Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global AI Therapy Chatbots Sales Value Market Share by Country (2027-2032) Table 40. MIT(Eliza) Company Information Table 41. MIT(Eliza) Business Overview Table 42. MIT(Eliza) AI Therapy Chatbots Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. MIT(Eliza) AI Therapy Chatbots Product Portfolio Table 44. MIT(Eliza) Recent Development Table 45. Pear Therapeutics Company Information Table 46. Pear Therapeutics Business Overview Table 47. Pear Therapeutics AI Therapy Chatbots Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Pear Therapeutics AI Therapy Chatbots Product Portfolio Table 49. Pear Therapeutics Recent Development Table 50. Woebot Health Company Information Table 51. Woebot Health Business Overview Table 52. Woebot Health AI Therapy Chatbots Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Woebot Health AI Therapy Chatbots Product Portfolio Table 54. Woebot Health Recent Development Table 55. Expresso Company Information Table 56. Expresso Business Overview Table 57. Expresso AI Therapy Chatbots Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Expresso AI Therapy Chatbots Product Portfolio Table 59. Expresso Recent Development Table 60. Wysa Company Information Table 61. Wysa Business Overview Table 62. Wysa AI Therapy Chatbots Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Wysa AI Therapy Chatbots Product Portfolio Table 64. Wysa Recent Development Table 65. X2AI Company Information Table 66. X2AI Business Overview Table 67. X2AI AI Therapy Chatbots Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. X2AI AI Therapy Chatbots Product Portfolio Table 69. X2AI Recent Development Table 70. Huma Company Information Table 71. Huma Business Overview Table 72. Huma AI Therapy Chatbots Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Huma AI Therapy Chatbots Product Portfolio Table 74. Huma Recent Development Table 75. Youper Company Information Table 76. Youper Business Overview Table 77. Youper AI Therapy Chatbots Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Youper AI Therapy Chatbots Product Portfolio Table 79. Youper Recent Development Table 80. Replika Company Information Table 81. Replika Business Overview Table 82. Replika AI Therapy Chatbots Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Replika AI Therapy Chatbots Product Portfolio Table 84. Replika Recent Development Table 85. Mindstrong Health Company Information Table 86. Mindstrong Health Business Overview Table 87. Mindstrong Health AI Therapy Chatbots Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Mindstrong Health AI Therapy Chatbots Product Portfolio Table 89. Mindstrong Health Recent Development Table 90. Marigold Health Company Information Table 91. Marigold Health Business Overview Table 92. Marigold Health AI Therapy Chatbots Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Marigold Health AI Therapy Chatbots Product Portfolio Table 94. Marigold Health Recent Development Table 95. Miyourobot Company Information Table 96. Miyourobot Business Overview Table 97. Miyourobot AI Therapy Chatbots Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Miyourobot AI Therapy Chatbots Product Portfolio Table 99. Miyourobot Recent Development Table 100. Xinchenai Company Information Table 101. Xinchenai Business Overview Table 102. Xinchenai AI Therapy Chatbots Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Xinchenai AI Therapy Chatbots Product Portfolio Table 104. Xinchenai Recent Development Table 105. Ai-beings Company Information Table 106. Ai-beings Business Overview Table 107. Ai-beings AI Therapy Chatbots Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Ai-beings AI Therapy Chatbots Product Portfolio Table 109. Ai-beings Recent Development Table 110. Leading-ai Company Information Table 111. Leading-ai Business Overview Table 112. Leading-ai AI Therapy Chatbots Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Leading-ai AI Therapy Chatbots Product Portfolio Table 114. Leading-ai Recent Development Table 115. Pku Company Information Table 116. Pku Business Overview Table 117. Pku AI Therapy Chatbots Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Pku AI Therapy Chatbots Product Portfolio Table 119. Pku Recent Development Table 120. Lx-tech Company Information Table 121. Lx-tech Business Overview Table 122. Lx-tech AI Therapy Chatbots Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Lx-tech AI Therapy Chatbots Product Portfolio Table 124. Lx-tech Recent Development Table 125. Csjbot Company Information Table 126. Csjbot Business Overview Table 127. Csjbot AI Therapy Chatbots Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Csjbot AI Therapy Chatbots Product Portfolio Table 129. Csjbot Recent Development Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. AI Therapy Chatbots Product Image Figure 2. Global AI Therapy Chatbots Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Therapy Chatbots Market Size (2021-2032) & (US$ Million) Figure 4. Global AI Therapy Chatbots Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Rogerian Psychotherapy Image Figure 8. Cognitive Behavior Therapy Image Figure 9. Global AI Therapy Chatbots Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global AI Therapy Chatbots Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global AI Therapy Chatbots Sales Value Share by Type (2021-2032) Figure 12. To C Image Figure 13. To B Image Figure 14. To G Image Figure 15. Others Image Figure 16. Global AI Therapy Chatbots Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global AI Therapy Chatbots Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global AI Therapy Chatbots Sales Value Share by Application (2021-2032) Figure 19. Global AI Therapy Chatbots Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global AI Therapy Chatbots Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America AI Therapy Chatbots Sales Value (2021-2032) & (US$ Million) Figure 22. North America AI Therapy Chatbots Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe AI Therapy Chatbots Sales Value (2021-2032) & (US$ Million) Figure 24. Europe AI Therapy Chatbots Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific AI Therapy Chatbots Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific AI Therapy Chatbots Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America AI Therapy Chatbots Sales Value (2021-2032) & (US$ Million) Figure 28. South America AI Therapy Chatbots Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa AI Therapy Chatbots Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa AI Therapy Chatbots Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA AI Therapy Chatbots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada AI Therapy Chatbots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico AI Therapy Chatbots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany AI Therapy Chatbots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France AI Therapy Chatbots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. AI Therapy Chatbots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy AI Therapy Chatbots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain AI Therapy Chatbots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia AI Therapy Chatbots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands AI Therapy Chatbots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries AI Therapy Chatbots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China AI Therapy Chatbots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan AI Therapy Chatbots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea AI Therapy Chatbots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India AI Therapy Chatbots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia AI Therapy Chatbots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia AI Therapy Chatbots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil AI Therapy Chatbots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina AI Therapy Chatbots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile AI Therapy Chatbots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia AI Therapy Chatbots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru AI Therapy Chatbots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia AI Therapy Chatbots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel AI Therapy Chatbots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE AI Therapy Chatbots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey AI Therapy Chatbots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran AI Therapy Chatbots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt AI Therapy Chatbots Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Rogerian Psychotherapy
  • Cognitive Behavior Therapy
Applications
  • To C
  • To B
  • To G
  • Others
Companies covered
  • MIT(Eliza)
  • Pear Therapeutics
  • Woebot Health
  • Expresso
  • Wysa
  • X2AI
  • Huma
  • Youper
  • Replika
  • Mindstrong Health
  • Marigold Health
  • Miyourobot
  • Xinchenai
  • Ai-beings
  • Leading-ai
  • Pku
  • Lx-tech
  • Csjbot

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global AI Therapy Chatbots Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global AI Therapy Chatbots Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 AI Therapy Chatbots Market Dynamics
  1. 2.1 AI Therapy Chatbots Industry Trends
  2. 2.2 AI Therapy Chatbots Industry Drivers
  3. 2.3 AI Therapy Chatbots Industry Opportunities and Challenges
  4. 2.4 AI Therapy Chatbots Industry Restraints
3 AI Therapy Chatbots Market by Company
  1. 3.1 Global AI Therapy Chatbots Company Revenue Ranking in 2025
  2. 3.2 Global AI Therapy Chatbots Revenue by Company (2021-2026)
  3. 3.3 Global AI Therapy Chatbots Company Ranking (2024-2026)
  4. 3.4 Global AI Therapy Chatbots Company Manufacturing Base and Headquarters
  5. 3.5 Global AI Therapy Chatbots Company Product Type and Application
  6. 3.6 Global AI Therapy Chatbots Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global AI Therapy Chatbots Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 AI Therapy Chatbots Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 AI Therapy Chatbots Market by Type
  1. 4.1 AI Therapy Chatbots Type Introduction
  2. 4.1.1 Rogerian Psychotherapy
  3. 4.1.2 Cognitive Behavior Therapy
  4. 4.2 Global AI Therapy Chatbots Sales Value by Type
  5. 4.2.1 Global AI Therapy Chatbots Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global AI Therapy Chatbots Sales Value by Type (2021-2032)
  7. 4.2.3 Global AI Therapy Chatbots Sales Value Share by Type (2021-2032)
5 AI Therapy Chatbots Market by Application
  1. 5.1 AI Therapy Chatbots Application Introduction
  2. 5.1.1 To C
  3. 5.1.2 To B
  4. 5.1.3 To G
  5. 5.1.4 Others
  6. 5.2 Global AI Therapy Chatbots Sales Value by Application
  7. 5.2.1 Global AI Therapy Chatbots Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global AI Therapy Chatbots Sales Value by Application (2021-2032)
  9. 5.2.3 Global AI Therapy Chatbots Sales Value Share by Application (2021-2032)
6 AI Therapy Chatbots Regional Value Analysis
  1. 6.1 Global AI Therapy Chatbots Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global AI Therapy Chatbots Sales Value by Region (2021-2032)
  3. 6.2.1 Global AI Therapy Chatbots Sales Value by Region: 2021-2026
  4. 6.2.2 Global AI Therapy Chatbots Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America AI Therapy Chatbots Sales Value (2021-2032)
  7. 6.3.2 North America AI Therapy Chatbots Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe AI Therapy Chatbots Sales Value (2021-2032)
  10. 6.4.2 Europe AI Therapy Chatbots Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific AI Therapy Chatbots Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific AI Therapy Chatbots Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America AI Therapy Chatbots Sales Value (2021-2032)
  16. 6.6.2 South America AI Therapy Chatbots Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa AI Therapy Chatbots Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa AI Therapy Chatbots Sales Value Share by Country, 2025 VS 2032
7 AI Therapy Chatbots Country-level Value Analysis
  1. 7.1 Global AI Therapy Chatbots Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global AI Therapy Chatbots Sales Value by Country (2021-2032)
  3. 7.2.1 Global AI Therapy Chatbots Sales Value by Country (2021-2026)
  4. 7.2.2 Global AI Therapy Chatbots Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 MIT(Eliza)
  2. 8.1.1 MIT(Eliza) Company Information
  3. 8.1.2 MIT(Eliza) Business Overview
  4. 8.1.3 MIT(Eliza) AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
  5. 8.1.4 MIT(Eliza) AI Therapy Chatbots Product Portfolio
  6. 8.1.5 MIT(Eliza) Recent Developments
  7. 8.2 Pear Therapeutics
  8. 8.2.1 Pear Therapeutics Company Information
  9. 8.2.2 Pear Therapeutics Business Overview
  10. 8.2.3 Pear Therapeutics AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pear Therapeutics AI Therapy Chatbots Product Portfolio
  12. 8.2.5 Pear Therapeutics Recent Developments
  13. 8.3 Woebot Health
  14. 8.3.1 Woebot Health Company Information
  15. 8.3.2 Woebot Health Business Overview
  16. 8.3.3 Woebot Health AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Woebot Health AI Therapy Chatbots Product Portfolio
  18. 8.3.5 Woebot Health Recent Developments
  19. 8.4 Expresso
  20. 8.4.1 Expresso Company Information
  21. 8.4.2 Expresso Business Overview
  22. 8.4.3 Expresso AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Expresso AI Therapy Chatbots Product Portfolio
  24. 8.4.5 Expresso Recent Developments
  25. 8.5 Wysa
  26. 8.5.1 Wysa Company Information
  27. 8.5.2 Wysa Business Overview
  28. 8.5.3 Wysa AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Wysa AI Therapy Chatbots Product Portfolio
  30. 8.5.5 Wysa Recent Developments
  31. 8.6 X2AI
  32. 8.6.1 X2AI Company Information
  33. 8.6.2 X2AI Business Overview
  34. 8.6.3 X2AI AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
  35. 8.6.4 X2AI AI Therapy Chatbots Product Portfolio
  36. 8.6.5 X2AI Recent Developments
  37. 8.7 Huma
  38. 8.7.1 Huma Company Information
  39. 8.7.2 Huma Business Overview
  40. 8.7.3 Huma AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Huma AI Therapy Chatbots Product Portfolio
  42. 8.7.5 Huma Recent Developments
  43. 8.8 Youper
  44. 8.8.1 Youper Company Information
  45. 8.8.2 Youper Business Overview
  46. 8.8.3 Youper AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Youper AI Therapy Chatbots Product Portfolio
  48. 8.8.5 Youper Recent Developments
  49. 8.9 Replika
  50. 8.9.1 Replika Company Information
  51. 8.9.2 Replika Business Overview
  52. 8.9.3 Replika AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Replika AI Therapy Chatbots Product Portfolio
  54. 8.9.5 Replika Recent Developments
  55. 8.10 Mindstrong Health
  56. 8.10.1 Mindstrong Health Company Information
  57. 8.10.2 Mindstrong Health Business Overview
  58. 8.10.3 Mindstrong Health AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Mindstrong Health AI Therapy Chatbots Product Portfolio
  60. 8.10.5 Mindstrong Health Recent Developments
  61. 8.11 Marigold Health
  62. 8.11.1 Marigold Health Company Information
  63. 8.11.2 Marigold Health Business Overview
  64. 8.11.3 Marigold Health AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Marigold Health AI Therapy Chatbots Product Portfolio
  66. 8.11.5 Marigold Health Recent Developments
  67. 8.12 Miyourobot
  68. 8.12.1 Miyourobot Company Information
  69. 8.12.2 Miyourobot Business Overview
  70. 8.12.3 Miyourobot AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Miyourobot AI Therapy Chatbots Product Portfolio
  72. 8.12.5 Miyourobot Recent Developments
  73. 8.13 Xinchenai
  74. 8.13.1 Xinchenai Company Information
  75. 8.13.2 Xinchenai Business Overview
  76. 8.13.3 Xinchenai AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Xinchenai AI Therapy Chatbots Product Portfolio
  78. 8.13.5 Xinchenai Recent Developments
  79. 8.14 Ai-beings
  80. 8.14.1 Ai-beings Company Information
  81. 8.14.2 Ai-beings Business Overview
  82. 8.14.3 Ai-beings AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Ai-beings AI Therapy Chatbots Product Portfolio
  84. 8.14.5 Ai-beings Recent Developments
  85. 8.15 Leading-ai
  86. 8.15.1 Leading-ai Company Information
  87. 8.15.2 Leading-ai Business Overview
  88. 8.15.3 Leading-ai AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Leading-ai AI Therapy Chatbots Product Portfolio
  90. 8.15.5 Leading-ai Recent Developments
  91. 8.16 Pku
  92. 8.16.1 Pku Company Information
  93. 8.16.2 Pku Business Overview
  94. 8.16.3 Pku AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Pku AI Therapy Chatbots Product Portfolio
  96. 8.16.5 Pku Recent Developments
  97. 8.17 Lx-tech
  98. 8.17.1 Lx-tech Company Information
  99. 8.17.2 Lx-tech Business Overview
  100. 8.17.3 Lx-tech AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Lx-tech AI Therapy Chatbots Product Portfolio
  102. 8.17.5 Lx-tech Recent Developments
  103. 8.18 Csjbot
  104. 8.18.1 Csjbot Company Information
  105. 8.18.2 Csjbot Business Overview
  106. 8.18.3 Csjbot AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Csjbot AI Therapy Chatbots Product Portfolio
  108. 8.18.5 Csjbot Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research